NANCY ELLEN DAVIDSON
Medical Practice in Baltimore, MD
License number
Pennsylvania MT001737T
Category
Medicine
Type
Graduate Medical Trainee
Address
Address
2
Baltimore, MD 21201
Pennsylvania
Pennsylvania
Personal information
See more information about NANCY ELLEN DAVIDSON at radaris.comName
Address
Phone
531 Weir Rd, Upper Chichester, PA 19014
4 Creekview Cir, West Chester, PA 19382
501 S Hanover St, Baltimore, MD 21201
630 Glen Meadow Rd, Richboro, PA 18954
5750 Kentucky Ave, Pittsburgh, PA 15232
Professional information
Aberrantly Methylated Genes As Markers Of Breast Malignancy
US Patent:
6835541, Dec 28, 2004
Filed:
Jan 28, 2002
Appl. No.:
10/059579
Inventors:
Saraswati Sukumar - Columbia MD
Ella Evron - Baltimore MD
William C. Dooley - Oklahoma City OK
Nicoletta Sacchi - North Potomac MD
Nancy Davidson - Baltimore MD
Mary Jo Fackler - Hunt Valley MD
Ella Evron - Baltimore MD
William C. Dooley - Oklahoma City OK
Nicoletta Sacchi - North Potomac MD
Nancy Davidson - Baltimore MD
Mary Jo Fackler - Hunt Valley MD
Assignee:
The Johns Hopkins University School of Medicine - Baltimore MD
International Classification:
C12Q 168
US Classification:
435 6, 435 911, 435 912, 536 231, 536 243
Abstract:
The invention is directed to a method of diagnosing a cell proliferative disorder of breast tissue by determining the methylation status of nucleic acids obtained from a subject. Aberrant methylation of several genes including TWIST, HOXA5, NES-1, retinoic acid receptor beta (RAR), estrogen receptor (ER), cyclin D2, WT-1, 14. 3. 3 sigma, HIN-1, RASSF1A, and combinations of such genes serve as markers of breast malignancy.
Nancy Davidson, Baltimore MD
Work:
Johns Hopkins Oncology Center
600 N Wolfe St, Baltimore, MD 21287 JHU Oncology
10755 Falls Rd, Lutherville Timonium, MD 21093 The Falls Concourse
10753 Falls Rd, Lutherville Timonium, MD 21093 University-Pittsburg Physician
300 Halket St, Pittsburgh, PA 15213 JHU Oncology
401 N Broadway St, Baltimore, MD 21287 University-Pittsburg Physician
5115 Centre Ave, Pittsburgh, PA 15232 JHU Anesthesiology ICU Pain Management
10755 Falls Rd, Lutherville Timonium, MD 21093
600 N Wolfe St, Baltimore, MD 21287 JHU Oncology
10755 Falls Rd, Lutherville Timonium, MD 21093 The Falls Concourse
10753 Falls Rd, Lutherville Timonium, MD 21093 University-Pittsburg Physician
300 Halket St, Pittsburgh, PA 15213 JHU Oncology
401 N Broadway St, Baltimore, MD 21287 University-Pittsburg Physician
5115 Centre Ave, Pittsburgh, PA 15232 JHU Anesthesiology ICU Pain Management
10755 Falls Rd, Lutherville Timonium, MD 21093
Aberrantly Methylated Genes As Markers Of Breast Malignancy
US Patent:
7858317, Dec 28, 2010
Filed:
Oct 9, 2008
Appl. No.:
12/248793
Inventors:
Saraswati Sukumar - Columbia MD, US
Ella Evron - Baltimore MD, US
William C. Dooley - Oklahoma City OK, US
Nicoletta Sacchi - North Potomac MD, US
Nancy Davidson - Baltimore MD, US
Mary Jo Fackler - Hunt Valley MD, US
Ella Evron - Baltimore MD, US
William C. Dooley - Oklahoma City OK, US
Nicoletta Sacchi - North Potomac MD, US
Nancy Davidson - Baltimore MD, US
Mary Jo Fackler - Hunt Valley MD, US
Assignee:
Johns Hopkins University School of Medicine - Baltimore MD
International Classification:
C12Q 1/68, C12P 19/34, C07H 21/02, C07H 21/04
US Classification:
435 6, 435 912, 536 231, 536 243
Abstract:
The invention is directed to a method of diagnosing a cell proliferative disorder of breast tissue by determining the methylation status of nucleic acids obtained from a subject. Aberrant methylation of several genes including TWIST, HOXA5, NES-1, retinoic acid receptor beta (RARĪ²), estrogen receptor (ER), cyclin D2, WT-1, 14. 3. 3 sigma, HIN-1, RASSF1A, and combinations of such genes serve as markers of breast malignancy.
Aberrantly Methylated Genes As Markers Of Breast Malignancy
US Patent:
2003001, Jan 23, 2003
Filed:
Jan 26, 2001
Appl. No.:
09/771357
Inventors:
Saraswati Sukumar - Columbia MD, US
Ella Evron - Baltimore MD, US
William Dooley - Oklahoma City OK, US
Nicoletta Sacchi - North Potomac MD, US
Nancy Davidson - Baltimore MD, US
Ella Evron - Baltimore MD, US
William Dooley - Oklahoma City OK, US
Nicoletta Sacchi - North Potomac MD, US
Nancy Davidson - Baltimore MD, US
International Classification:
C12Q001/68
US Classification:
435/006000
Abstract:
The invention is directed to a method of diagnosing a cell proliferative disorder of breast tissue by determining the methylation status of nucleic acids obtained from a subject. Aberrant methylation of several genes including TWIST, HOXA5, NES-1, retinoic acid receptor beta (RAR), estrogen receptor (ER), cyclin D2, WT-1, 14.3.3 sigma, and combinations of such genes serve as markers of breast malignancy.
Aberrantly Methylated Genes As Markers Of Breast Malignancy
US Patent:
2005019, Sep 1, 2005
Filed:
Jun 18, 2004
Appl. No.:
10/872229
Inventors:
Saraswati Sukumar - Columbia MD, US
Ella Evron - Baltimore MD, US
William Dooley - Oklahoma City OK, US
Nicoletta Sacchi - North Potomac MD, US
Nancy Davidson - Baltimore MD, US
Mary Fackler - Hunt Valley MD, US
Ella Evron - Baltimore MD, US
William Dooley - Oklahoma City OK, US
Nicoletta Sacchi - North Potomac MD, US
Nancy Davidson - Baltimore MD, US
Mary Fackler - Hunt Valley MD, US
International Classification:
C12Q001/68
US Classification:
435006000
Abstract:
The invention is directed to a method of diagnosing a cell proliferative disorder of breast tissue by determining the methylation status of nucleic acids obtained from a subject. Aberrant methylation of several genes including TWIST, HOXA5, NES-1, retinoic acid receptor beta (RARĪ²), estrogen receptor (ER), cyclin D2, WT-1, 14.3.3 sigma, HIN-1, RASSF1A, and combinations of such genes serve as markers of breast malignancy.